The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Nucleic Acid Therapies Market Research Report 2024
Synopsis
Small Nucleic Acid Therapies are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
The global Small Nucleic Acid Therapies market was valued at US$ 12490 million in 2023 and is anticipated to reach US$ 16120 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
North American market for Small Nucleic Acid Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Nucleic Acid Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Nucleic Acid Therapies in Neuromuscular Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Nucleic Acid Therapies include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid Therapies.
The Small Nucleic Acid Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Nucleic Acid Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Nucleic Acid Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Segment by Type
Antisense Oligonucleotides (ASO)
siRNA
mRNA
Segment by Application
Neuromuscular Diseases
hATTR
COVID-19
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Small Nucleic Acid Therapies are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
The global Small Nucleic Acid Therapies market was valued at US$ 12490 million in 2023 and is anticipated to reach US$ 16120 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
North American market for Small Nucleic Acid Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Nucleic Acid Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Nucleic Acid Therapies in Neuromuscular Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Nucleic Acid Therapies include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid Therapies.
The Small Nucleic Acid Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Nucleic Acid Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Nucleic Acid Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Segment by Type
Antisense Oligonucleotides (ASO)
siRNA
mRNA
Segment by Application
Neuromuscular Diseases
hATTR
COVID-19
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Nucleic Acid Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antisense Oligonucleotides (ASO)
1.2.3 siRNA
1.2.4 mRNA
1.3 Market by Application
1.3.1 Global Small Nucleic Acid Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neuromuscular Diseases
1.3.3 hATTR
1.3.4 COVID-19
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Nucleic Acid Therapies Market Perspective (2019-2030)
2.2 Global Small Nucleic Acid Therapies Growth Trends by Region
2.2.1 Global Small Nucleic Acid Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Nucleic Acid Therapies Historic Market Size by Region (2019-2024)
2.2.3 Small Nucleic Acid Therapies Forecasted Market Size by Region (2025-2030)
2.3 Small Nucleic Acid Therapies Market Dynamics
2.3.1 Small Nucleic Acid Therapies Industry Trends
2.3.2 Small Nucleic Acid Therapies Market Drivers
2.3.3 Small Nucleic Acid Therapies Market Challenges
2.3.4 Small Nucleic Acid Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Nucleic Acid Therapies Players by Revenue
3.1.1 Global Top Small Nucleic Acid Therapies Players by Revenue (2019-2024)
3.1.2 Global Small Nucleic Acid Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Small Nucleic Acid Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Nucleic Acid Therapies Revenue
3.4 Global Small Nucleic Acid Therapies Market Concentration Ratio
3.4.1 Global Small Nucleic Acid Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Nucleic Acid Therapies Revenue in 2023
3.5 Global Key Players of Small Nucleic Acid Therapies Head office and Area Served
3.6 Global Key Players of Small Nucleic Acid Therapies, Product and Application
3.7 Global Key Players of Small Nucleic Acid Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Nucleic Acid Therapies Breakdown Data by Type
4.1 Global Small Nucleic Acid Therapies Historic Market Size by Type (2019-2024)
4.2 Global Small Nucleic Acid Therapies Forecasted Market Size by Type (2025-2030)
5 Small Nucleic Acid Therapies Breakdown Data by Application
5.1 Global Small Nucleic Acid Therapies Historic Market Size by Application (2019-2024)
5.2 Global Small Nucleic Acid Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Nucleic Acid Therapies Market Size (2019-2030)
6.2 North America Small Nucleic Acid Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Nucleic Acid Therapies Market Size by Country (2019-2024)
6.4 North America Small Nucleic Acid Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Nucleic Acid Therapies Market Size (2019-2030)
7.2 Europe Small Nucleic Acid Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Nucleic Acid Therapies Market Size by Country (2019-2024)
7.4 Europe Small Nucleic Acid Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Nucleic Acid Therapies Market Size (2019-2030)
8.2 Asia-Pacific Small Nucleic Acid Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Nucleic Acid Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Nucleic Acid Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Nucleic Acid Therapies Market Size (2019-2030)
9.2 Latin America Small Nucleic Acid Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Nucleic Acid Therapies Market Size by Country (2019-2024)
9.4 Latin America Small Nucleic Acid Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Nucleic Acid Therapies Market Size (2019-2030)
10.2 Middle East & Africa Small Nucleic Acid Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Nucleic Acid Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Nucleic Acid Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Details
11.1.2 Sarepta Therapeutics Business Overview
11.1.3 Sarepta Therapeutics Small Nucleic Acid Therapies Introduction
11.1.4 Sarepta Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.1.5 Sarepta Therapeutics Recent Development
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Business Overview
11.2.3 Ionis Pharmaceuticals Small Nucleic Acid Therapies Introduction
11.2.4 Ionis Pharmaceuticals Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.2.5 Ionis Pharmaceuticals Recent Development
11.3 Alnylam
11.3.1 Alnylam Company Details
11.3.2 Alnylam Business Overview
11.3.3 Alnylam Small Nucleic Acid Therapies Introduction
11.3.4 Alnylam Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.3.5 Alnylam Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Small Nucleic Acid Therapies Introduction
11.4.4 Biogen Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.4.5 Biogen Recent Development
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Details
11.5.2 Nippon Shinyaku Business Overview
11.5.3 Nippon Shinyaku Small Nucleic Acid Therapies Introduction
11.5.4 Nippon Shinyaku Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.5.5 Nippon Shinyaku Recent Development
11.6 Sobi
11.6.1 Sobi Company Details
11.6.2 Sobi Business Overview
11.6.3 Sobi Small Nucleic Acid Therapies Introduction
11.6.4 Sobi Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.6.5 Sobi Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Small Nucleic Acid Therapies Introduction
11.7.4 Novartis Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 BioNTech
11.8.1 BioNTech Company Details
11.8.2 BioNTech Business Overview
11.8.3 BioNTech Small Nucleic Acid Therapies Introduction
11.8.4 BioNTech Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.8.5 BioNTech Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Small Nucleic Acid Therapies Introduction
11.9.4 Pfizer Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Details
11.10.2 Moderna Therapeutics Business Overview
11.10.3 Moderna Therapeutics Small Nucleic Acid Therapies Introduction
11.10.4 Moderna Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.10.5 Moderna Therapeutics Recent Development
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Details
11.11.2 Jazz Pharmaceuticals Business Overview
11.11.3 Jazz Pharmaceuticals Small Nucleic Acid Therapies Introduction
11.11.4 Jazz Pharmaceuticals Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.11.5 Jazz Pharmaceuticals Recent Development
11.12 CureVac
11.12.1 CureVac Company Details
11.12.2 CureVac Business Overview
11.12.3 CureVac Small Nucleic Acid Therapies Introduction
11.12.4 CureVac Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.12.5 CureVac Recent Development
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Details
11.13.2 Regulus Therapeutics Business Overview
11.13.3 Regulus Therapeutics Small Nucleic Acid Therapies Introduction
11.13.4 Regulus Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.13.5 Regulus Therapeutics Recent Development
11.14 ProQR
11.14.1 ProQR Company Details
11.14.2 ProQR Business Overview
11.14.3 ProQR Small Nucleic Acid Therapies Introduction
11.14.4 ProQR Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.14.5 ProQR Recent Development
11.15 Secarna
11.15.1 Secarna Company Details
11.15.2 Secarna Business Overview
11.15.3 Secarna Small Nucleic Acid Therapies Introduction
11.15.4 Secarna Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.15.5 Secarna Recent Development
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Details
11.16.2 MiNA Therapeutics Business Overview
11.16.3 MiNA Therapeutics Small Nucleic Acid Therapies Introduction
11.16.4 MiNA Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.16.5 MiNA Therapeutics Recent Development
11.17 Sylentis
11.17.1 Sylentis Company Details
11.17.2 Sylentis Business Overview
11.17.3 Sylentis Small Nucleic Acid Therapies Introduction
11.17.4 Sylentis Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.17.5 Sylentis Recent Development
11.18 Arrowhead
11.18.1 Arrowhead Company Details
11.18.2 Arrowhead Business Overview
11.18.3 Arrowhead Small Nucleic Acid Therapies Introduction
11.18.4 Arrowhead Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.18.5 Arrowhead Recent Development
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Details
11.19.2 Silence Therapeutics Business Overview
11.19.3 Silence Therapeutics Small Nucleic Acid Therapies Introduction
11.19.4 Silence Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.19.5 Silence Therapeutics Recent Development
11.20 Dicerna
11.20.1 Dicerna Company Details
11.20.2 Dicerna Business Overview
11.20.3 Dicerna Small Nucleic Acid Therapies Introduction
11.20.4 Dicerna Revenue in Small Nucleic Acid Therapies Business (2019-2024)
11.20.5 Dicerna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Small Nucleic Acid Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antisense Oligonucleotides (ASO)
Table 3. Key Players of siRNA
Table 4. Key Players of mRNA
Table 5. Global Small Nucleic Acid Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Small Nucleic Acid Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Small Nucleic Acid Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Small Nucleic Acid Therapies Market Share by Region (2019-2024)
Table 9. Global Small Nucleic Acid Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Small Nucleic Acid Therapies Market Share by Region (2025-2030)
Table 11. Small Nucleic Acid Therapies Market Trends
Table 12. Small Nucleic Acid Therapies Market Drivers
Table 13. Small Nucleic Acid Therapies Market Challenges
Table 14. Small Nucleic Acid Therapies Market Restraints
Table 15. Global Small Nucleic Acid Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Small Nucleic Acid Therapies Market Share by Players (2019-2024)
Table 17. Global Top Small Nucleic Acid Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid Therapies as of 2023)
Table 18. Ranking of Global Top Small Nucleic Acid Therapies Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Small Nucleic Acid Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Small Nucleic Acid Therapies, Headquarters and Area Served
Table 21. Global Key Players of Small Nucleic Acid Therapies, Product and Application
Table 22. Global Key Players of Small Nucleic Acid Therapies, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Nucleic Acid Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Small Nucleic Acid Therapies Revenue Market Share by Type (2019-2024)
Table 26. Global Small Nucleic Acid Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Small Nucleic Acid Therapies Revenue Market Share by Type (2025-2030)
Table 28. Global Small Nucleic Acid Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Small Nucleic Acid Therapies Revenue Market Share by Application (2019-2024)
Table 30. Global Small Nucleic Acid Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Small Nucleic Acid Therapies Revenue Market Share by Application (2025-2030)
Table 32. North America Small Nucleic Acid Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Small Nucleic Acid Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Small Nucleic Acid Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Small Nucleic Acid Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Small Nucleic Acid Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Small Nucleic Acid Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Small Nucleic Acid Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Small Nucleic Acid Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Small Nucleic Acid Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Small Nucleic Acid Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Small Nucleic Acid Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Small Nucleic Acid Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Small Nucleic Acid Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Small Nucleic Acid Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Small Nucleic Acid Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 47. Sarepta Therapeutics Company Details
Table 48. Sarepta Therapeutics Business Overview
Table 49. Sarepta Therapeutics Small Nucleic Acid Therapies Product
Table 50. Sarepta Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 51. Sarepta Therapeutics Recent Development
Table 52. Ionis Pharmaceuticals Company Details
Table 53. Ionis Pharmaceuticals Business Overview
Table 54. Ionis Pharmaceuticals Small Nucleic Acid Therapies Product
Table 55. Ionis Pharmaceuticals Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 56. Ionis Pharmaceuticals Recent Development
Table 57. Alnylam Company Details
Table 58. Alnylam Business Overview
Table 59. Alnylam Small Nucleic Acid Therapies Product
Table 60. Alnylam Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 61. Alnylam Recent Development
Table 62. Biogen Company Details
Table 63. Biogen Business Overview
Table 64. Biogen Small Nucleic Acid Therapies Product
Table 65. Biogen Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 66. Biogen Recent Development
Table 67. Nippon Shinyaku Company Details
Table 68. Nippon Shinyaku Business Overview
Table 69. Nippon Shinyaku Small Nucleic Acid Therapies Product
Table 70. Nippon Shinyaku Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 71. Nippon Shinyaku Recent Development
Table 72. Sobi Company Details
Table 73. Sobi Business Overview
Table 74. Sobi Small Nucleic Acid Therapies Product
Table 75. Sobi Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 76. Sobi Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Small Nucleic Acid Therapies Product
Table 80. Novartis Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. BioNTech Company Details
Table 83. BioNTech Business Overview
Table 84. BioNTech Small Nucleic Acid Therapies Product
Table 85. BioNTech Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 86. BioNTech Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Small Nucleic Acid Therapies Product
Table 90. Pfizer Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Moderna Therapeutics Company Details
Table 93. Moderna Therapeutics Business Overview
Table 94. Moderna Therapeutics Small Nucleic Acid Therapies Product
Table 95. Moderna Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 96. Moderna Therapeutics Recent Development
Table 97. Jazz Pharmaceuticals Company Details
Table 98. Jazz Pharmaceuticals Business Overview
Table 99. Jazz Pharmaceuticals Small Nucleic Acid Therapies Product
Table 100. Jazz Pharmaceuticals Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 101. Jazz Pharmaceuticals Recent Development
Table 102. CureVac Company Details
Table 103. CureVac Business Overview
Table 104. CureVac Small Nucleic Acid Therapies Product
Table 105. CureVac Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 106. CureVac Recent Development
Table 107. Regulus Therapeutics Company Details
Table 108. Regulus Therapeutics Business Overview
Table 109. Regulus Therapeutics Small Nucleic Acid Therapies Product
Table 110. Regulus Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 111. Regulus Therapeutics Recent Development
Table 112. ProQR Company Details
Table 113. ProQR Business Overview
Table 114. ProQR Small Nucleic Acid Therapies Product
Table 115. ProQR Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 116. ProQR Recent Development
Table 117. Secarna Company Details
Table 118. Secarna Business Overview
Table 119. Secarna Small Nucleic Acid Therapies Product
Table 120. Secarna Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 121. Secarna Recent Development
Table 122. MiNA Therapeutics Company Details
Table 123. MiNA Therapeutics Business Overview
Table 124. MiNA Therapeutics Small Nucleic Acid Therapies Product
Table 125. MiNA Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 126. MiNA Therapeutics Recent Development
Table 127. Sylentis Company Details
Table 128. Sylentis Business Overview
Table 129. Sylentis Small Nucleic Acid Therapies Product
Table 130. Sylentis Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 131. Sylentis Recent Development
Table 132. Arrowhead Company Details
Table 133. Arrowhead Business Overview
Table 134. Arrowhead Small Nucleic Acid Therapies Product
Table 135. Arrowhead Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 136. Arrowhead Recent Development
Table 137. Silence Therapeutics Company Details
Table 138. Silence Therapeutics Business Overview
Table 139. Silence Therapeutics Small Nucleic Acid Therapies Product
Table 140. Silence Therapeutics Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 141. Silence Therapeutics Recent Development
Table 142. Dicerna Company Details
Table 143. Dicerna Business Overview
Table 144. Dicerna Small Nucleic Acid Therapies Product
Table 145. Dicerna Revenue in Small Nucleic Acid Therapies Business (2019-2024) & (US$ Million)
Table 146. Dicerna Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Small Nucleic Acid Therapies Picture
Figure 2. Global Small Nucleic Acid Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Small Nucleic Acid Therapies Market Share by Type: 2023 VS 2030
Figure 4. Antisense Oligonucleotides (ASO) Features
Figure 5. siRNA Features
Figure 6. mRNA Features
Figure 7. Global Small Nucleic Acid Therapies Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Small Nucleic Acid Therapies Market Share by Application: 2023 VS 2030
Figure 9. Neuromuscular Diseases Case Studies
Figure 10. hATTR Case Studies
Figure 11. COVID-19 Case Studies
Figure 12. Other Case Studies
Figure 13. Small Nucleic Acid Therapies Report Years Considered
Figure 14. Global Small Nucleic Acid Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Small Nucleic Acid Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Small Nucleic Acid Therapies Market Share by Region: 2023 VS 2030
Figure 17. Global Small Nucleic Acid Therapies Market Share by Players in 2023
Figure 18. Global Top Small Nucleic Acid Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid Therapies as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Small Nucleic Acid Therapies Revenue in 2023
Figure 20. North America Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Small Nucleic Acid Therapies Market Share by Country (2019-2030)
Figure 22. United States Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Small Nucleic Acid Therapies Market Share by Country (2019-2030)
Figure 26. Germany Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Small Nucleic Acid Therapies Market Share by Region (2019-2030)
Figure 34. China Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Small Nucleic Acid Therapies Market Share by Country (2019-2030)
Figure 42. Mexico Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Small Nucleic Acid Therapies Market Share by Country (2019-2030)
Figure 46. Turkey Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. UAE Small Nucleic Acid Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Sarepta Therapeutics Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 51. Alnylam Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 52. Biogen Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 53. Nippon Shinyaku Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 54. Sobi Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 56. BioNTech Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 58. Moderna Therapeutics Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 60. CureVac Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 61. Regulus Therapeutics Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 62. ProQR Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 63. Secarna Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 64. MiNA Therapeutics Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 65. Sylentis Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 66. Arrowhead Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 67. Silence Therapeutics Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 68. Dicerna Revenue Growth Rate in Small Nucleic Acid Therapies Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
